Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population

British Journal of Dermatology

Volumn 167, Issue 2, 2012, Pages 306-313

  Yi, S M ^a   Son, S W ^a   Lee, K G ^a   Kim, S H ^a   Lee, S K ^a   Cho, E R ^a   Kim, I H ^a   Shin, C ^a  

^a Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; METABOLIC SYNDROME X; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; WAIST CIRCUMFERENCE;

ALOPECIA; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REPUBLIC OF KOREA; SEX DISTRIBUTION;

EID: 84864413524     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10978.x     Document Type: Article

References (46)

1. Trueb RM,. Molecular mechanisms of androgenetic alopecia. Exp Gerontol 2002; 37: 981-90.
2. Hamilton JB,. Effect of castration in adolescent and young adult males upon further changes in the proportions of bare and hairy scalp. J Clin Endocrinol Metab 1960; 20: 1309-18.
3. Cotton SG, Nixon JM, Carpenter RG, Evans DW,. Factors discriminating men with coronary heart disease from healthy controls. Br Heart J 1972; 34: 458-64.
4. Sasmaz S, Senol M, Ozcan A, et al. The risk of coronary heart disease in men with androgenetic alopecia. J Eur Acad Dermatol Venereol 1999; 12: 123-5.
5. Mansouri P, Mortazavi M, Eslami M, Mazinani M,. Androgenetic alopecia and coronary artery disease in women. Dermatol Online J 2005; 11: 2.
6. Matilainen V, Koskela P, Keinanen-Kiukaanniemi S,. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000; 356: 1165-6.
7. Ahouansou S, Le Toumelin P, Crickx B, Descamps V,. Association of androgenetic alopecia and hypertension. Eur J Dermatol 2007; 17: 220-2.
8. Sadighha A, Zahed GM,. Evaluation of lipid levels in androgenetic alopecia in comparison with control group. J Eur Acad Dermatol Venereol 2009; 23: 80-1.
9. Hirsso P, Rajala U, Hiltunen L, et al. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology 2007; 214: 125-9.
10. Hawk E, Breslow RA, Graubard BI,. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 2000; 9: 523-7.
11. Oh BR, Kim SJ, Moon JD, et al. Association of benign prostatic hyperplasia with male pattern baldness. Urology 1998; 51: 744-8.
12. Mosley JG, Gibbs AC,. Premature grey hair and hair loss among smokers: a new opportunity for health education? Br Med J 1996; 313: 1616.
13. Su LH, Chen TH,. Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Arch Dermatol 2007; 143: 1401-6.
14. Nabaie L, Kavand S, Robati RM, et al. Androgenic alopecia and insulin resistance: are they really related? Clin Exp Dermatol 2009; 34: 694-7.
15. Shahar E, Heiss G, Rosamond WD, Szklo M,. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol 2008; 167: 676-83.
16. Abdel Fattah NS, Darwish YW,. Androgenetic alopecia and insulin resistance: are they truly associated? Int J Dermatol 2011; 50: 417-22.
17. Matilainen V, Laakso M, Hirsso P, et al. Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study. J Cardiovasc Risk 2003; 10: 227-31.
18. Severi G, Sinclair R, Hopper JL, et al. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol 2003; 149: 1207-13.
19. Assmann G, Schulte H, Seedorf U,. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. Int J Obes (Lond) 2008; 32 (Suppl. 2): S11-16.
20. Arias-Santiago S, Gutierrez-Salmeron MT, Castellote-Caballero L, et al. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol 2010; 63: 420-9.
21. Su LH, Chen TH,. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. Br J Dermatol 2010; 163: 371-7.
22. Kim J, In K, You S, et al. Prevalence of sleep-disordered breathing in middle-aged Korean men and women. Am J Respir Crit Care Med 2004; 170: 1108-13.
23. Norwood OT,. Male pattern baldness: classification and incidence. South Med J 1975; 68: 1359-65.
24. Ludwig E,. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247-54.
25. Expert Panel on Detection, Evaluation, and Treatment of HIgh Cholesterol in Adulsts. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc 2001; 285: 2486-97.
26. WHO/IASO/IOTF. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications Australia, 2000.
27. Narkiewicz K, Kjeldsen SE, Hedner T,. Is smoking a causative factor of hypertension? Blood Press 2005; 14: 69-71.
28. Rebora A,. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. Arch Dermatol 2001; 137: 943-7.
29. Matilainen VA, Makinen PK, Keinanen-Kiukaanniemi SM,. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study. J Cardiovasc Risk 2001; 8: 147-51.
30. Herrera CR, D'Agostino RB, Gerstman BB, et al. Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol 1995; 142: 828-33.
31. Lotufo PA, Chae CU, Ajani UA, et al. Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med 2000; 160: 165-71.
32. Lesko SM, Rosenberg L, Shapiro S,. A case-control study of baldness in relation to myocardial infarction in men. J Am Med Assoc 1993; 269: 998-1003.
33. Hirsso P, Laakso M, Matilainen V, et al. Association of insulin resistance linked diseases and hair loss in elderly men Finnish population-based study. Cent Eur J Public Health 2006; 14: 78-81.
34. Ellis JA, Stebbing M, Harrap SB,. Male pattern baldness is not associated with established cardiovascular risk factors in the general population. Clin Sci (Lond) 2001; 100: 401-4.
35. Hillmer AM, Flaquer A, Hanneken S, et al. Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. Am J Hum Genet 2008; 82: 737-43.
36. Hillmer AM, Brockschmidt FF, Hanneken S, et al. Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 2008; 40: 1279-81.
37. Rushton DH, Ramsay ID, James KC, et al. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol 1990; 123: 187-97.
38. Schmidt JB, Lindmaier A, Trenz A, et al. Hormone studies in females with androgenic hairloss. Gynecol Obstet Invest 1991; 31: 235-9.
39. Price VH, Roberts JL, Hordinsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000; 43: 768-76.
40. Vexiau P, Chaspoux C, Boudou P, et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol 2002; 146: 992-9.
41. Chiu HY, Lin SJ,. Female pattern hair loss in a patient with 17alpha-hydroxylase deficiency. Acta Derm Venereol 2010; 90: 329-30.
42. Orme S, Cullen DR, Messenger AG,. Diffuse female hair loss: are androgens necessary? Br J Dermatol 1999; 141: 521-3.
43. Cousen P, Messenger A,. Female pattern hair loss in complete androgen insensitivity syndrome. Br J Dermatol 2010; 162: 1135-7.
44. Paik JH, Yoon JB, Sim WY, et al. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol 2001; 145: 95-9.
45. Xu F, Sheng YY, Mu ZL, et al. Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study. Br J Dermatol 2009; 160: 629-32.
46. Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol 2010; 162: 843-7.